Overview Dividends

(CX) Cemex SAB de CV - Ratings and Ratios

Exchange: NYSE • Country: Mexico • Currency: USD • Type: Common Stock • ISIN: US1512908898

Cement, Concrete, Aggregates, Services

Construction Materials
Market Cap in USD: 16,670m

IPO / Inception: 1999-09-15
Return 12m vs S&P 500: 72.2%

EPS (Earnings per Share)

EPS CAGR: -8.81%
EPS Trend: 20.8%

Last SUE: -0.73
Qual. Beats: 0

Revenue

Rev. CAGR: 4.71%
Rev. Trend: 36.3%

Last SUE: 0.04
Qual. Beats: 0

Dividends

Dividend Yield	0.76%
Yield on Cost 5y	1.59%
Yield CAGR 5y	39.68%
Payout Consistency	38.4%
Payout Ratio	9.4%

Risk via 5d forecast
Volatility	33.7%
Value at Risk 5%th	54.5%
Relative Tail Risk	-1.58%

Reward TTM
Sharpe Ratio	2.08
Alpha	90.53
CAGR/Max DD	0.77

Character TTM
Hurst Exponent	0.471
Beta	0.821
Beta Downside	1.052

Drawdowns 3y
Max DD	44.37%
Mean DD	16.46%
Median DD	13.08%

Description: CX Cemex SAB de CV January 02, 2026

CEMEX, S.A.B. de C.V. (NYSE: CX) is a Mexico-based, globally diversified builder of construction materials, producing cement, ready-mix concrete, aggregates, and a suite of urban-development solutions. Its product portfolio spans gray and white Portland cement, specialty blends for oil-well applications, a wide array of concrete mixes (including rapid-setting, fiber-reinforced, and antibacterial types), and recycled-content aggregates, complemented by logistics, engineering, waste-management, and prefabricated construction services.

Key quantitative points (2023 FY): total revenue ≈ $15.5 bn, EBITDA margin ≈ 12 %, and a net debt-to-EBITDA ratio of roughly 3.1×, reflecting a capital-intensive balance sheet but steady cash generation. The business is heavily influenced by macro-drivers such as global infrastructure spending (projected ~4 % CAGR through 2028), residential construction cycles in the United States and Europe, and the industry’s transition toward lower-carbon clinker substitutes and alternative fuels, which can affect both cost structure and regulatory risk.

For a deeper quantitative breakdown, you might explore ValueRay’s analyst toolkit to see how these fundamentals compare across peers.

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (1.36b TTM) > 0 and > 6% of Revenue (6% = 949.9m TTM)

FCFTA 0.03 (>2.0%) and ΔFCFTA 1.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -3.60% (prev -0.66%; Δ -2.94pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.07 (>3.0%) and CFO 2.09b > Net Income 1.36b (YES >=105%, WARN >=100%)

Net Debt (1.88b) to EBITDA (2.04b) ratio: 0.92 <= 3.0 (WARN <= 3.5)

Current Ratio 0.91 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.47b) change vs 12m ago -3.11% (target <= -2.0% for YES)

Gross Margin 32.05% (prev 33.44%; Δ -1.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 55.55% (prev 58.64%; Δ -3.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.17 (EBITDA TTM 2.04b / Interest Expense TTM 517.0m) >= 6 (WARN >= 3)

Altman Z'' 1.39

(A) -0.02 = (Total Current Assets 5.96b - Total Current Liabilities 6.53b) / Total Assets 29.01b

(B) 0.22 = Retained Earnings (Balance) 6.43b / Total Assets 29.01b

(D) 0.39 = Book Value of Equity 5.91b / Total Liabilities 15.09b

Total Rating: 1.39 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 64.09

1. Piotroski 6.50pt

2. FCF Yield 5.40%

3. FCF Margin 6.33%

4. Debt/Equity 0.23

5. Debt/Ebitda 0.92

6. ROIC - WACC (= -0.54)%

7. RoE 10.46%

8. Rev. Trend 36.26%

9. EPS Trend 20.80%

What is the price of CX shares?

As of January 08, 2026, the stock is trading at USD 11.53 with a total of 4,467,074 shares traded.
Over the past week, the price has changed by +0.35%, over one month by +5.21%, over three months by +26.95% and over the past year by +104.15%.

Is CX a buy, sell or hold?

Cemex SAB de CV has received a consensus analysts rating of 3.79. Therefor, it is recommend to hold CX.

Strong Buy: 3
Buy: 6
Hold: 4
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the CX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	11.5	0%
Analysts Target Price	11.5	0%
ValueRay Target Price	13.6	17.8%

CX Fundamental Data Overview January 03, 2026

Market Cap USD = 16.67b (16.67b USD * 1.0 USD.USD)
P/E Trailing = 12.6264
P/E Forward = 15.0602
P/S = 1.0504
P/B = 1.2255
P/EG = 0.1074
Beta = 1.115
Revenue TTM = 15.83b USD
EBIT TTM = 1.64b USD
EBITDA TTM = 2.04b USD
Long Term Debt = 5.14b USD (from longTermDebt, last quarter)
Short Term Debt = 289.0m USD (from shortTermDebt, last quarter)
Debt = 3.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.88b USD (from netDebt column, last quarter)
Enterprise Value = 18.55b USD (16.67b + Debt 3.08b - CCE 1.20b)
Interest Coverage Ratio = 3.17 (Ebit TTM 1.64b / Interest Expense TTM 517.0m)
FCF Yield = 5.40% (FCF TTM 1.00b / Enterprise Value 18.55b)
FCF Margin = 6.33% (FCF TTM 1.00b / Revenue TTM 15.83b)
Net Margin = 8.62% (Net Income TTM 1.36b / Revenue TTM 15.83b)
Gross Margin = 32.05% ((Revenue TTM 15.83b - Cost of Revenue TTM 10.76b) / Revenue TTM)
Gross Margin QoQ = 33.58% (prev 33.96%)
Tobins Q-Ratio = 0.64 (Enterprise Value 18.55b / Total Assets 29.01b)
Interest Expense / Debt = 3.58% (Interest Expense 110.3m / Debt 3.08b)
Taxrate = 33.55% (121.0m / 360.8m)
NOPAT = 1.09b (EBIT 1.64b * (1 - 33.55%))
Current Ratio = 0.91 (Total Current Assets 5.96b / Total Current Liabilities 6.53b)
Debt / Equity = 0.23 (Debt 3.08b / totalStockholderEquity, last quarter 13.60b)
Debt / EBITDA = 0.92 (Net Debt 1.88b / EBITDA 2.04b)
Debt / FCF = 1.88 (Net Debt 1.88b / FCF TTM 1.00b)
Total Stockholder Equity = 13.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.70% (Net Income 1.36b / Total Assets 29.01b)
RoE = 10.46% (Net Income TTM 1.36b / Total Stockholder Equity 13.05b)
RoCE = 9.01% (EBIT 1.64b / Capital Employed (Equity 13.05b + L.T.Debt 5.14b))
RoIC = 7.46% (NOPAT 1.09b / Invested Capital 14.60b)
WACC = 8.00% (E(16.67b)/V(19.75b) * Re(9.04%) + D(3.08b)/V(19.75b) * Rd(3.58%) * (1-Tc(0.34)))
Discount Rate = 9.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.75%
[DCF Debug] Terminal Value 74.22% ; FCFE base≈841.0m ; Y1≈815.9m ; Y5≈814.5m
Fair Price DCF = 8.37 (DCF Value 12.14b / Shares Outstanding 1.45b; 5y FCF grow -4.15% → 3.0% )
EPS Correlation: 20.80 | EPS CAGR: -8.81% | SUE: -0.73 | # QB: 0
Revenue Correlation: 36.26 | Revenue CAGR: 4.71% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=+0.006 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=0.79 | Chg30d=-0.006 | Revisions Net=+0 | Growth EPS=-1.0% | Growth Revenue=+5.1%

Additional Sources for CX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle